Skip to Content

Ablavar

Previous name: Vasovist
Active Substance: gadofosveset trisodium
Common Name: gadofosveset trisodium
ATC Code: V08CA
Marketing Authorisation Holder: TMC Pharma Services Ltd.
Active Substance: gadofosveset trisodium
Status: Withdrawn
Authorisation Date: 2005-10-03
Therapeutic Area: Magnetic Resonance Angiography
Pharmacotherapeutic Group: Contrast media

Therapeutic Indication

This medicinal product is for diagnostic use only.

AblavarĀ is indicated for contrast-enhanced magnetic resonance angiography (CE-MRA) for visualisation of abdominal or limb vessels in adults only, with suspected or known vascular disease.

The marketing authorisation for Ablavar has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide